Literature DB >> 10367915

The management of superficial candidiasis.

R J Hay1.   

Abstract

Superficial Candida infection includes several common conditions, most often related to some underlying local or systemic predisposition. Appropriate identification of the pathogen is important in the management of candidiasis as the result of differences in susceptibility among species and strains of Candida to different antifungal drugs. Treatment options are reviewed for oropharyngeal candidiasis, vaginal candidiasis, cutaneous candidiasis, paronychia and onychomycosis, and chronic mucocutaneous candidiasis. Because of the importance of predisposing conditions for candidiasis, adjunctive measures to abate these may be useful, although they are seldom effective in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367915     DOI: 10.1016/s0190-9622(99)70396-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Occurrence of Candida strains in cases of paronychia.

Authors:  E Dorko; J Jautová; E Pilipcinec; L Tkáciková
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

2.  A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.

Authors:  Brice Enjalbert; Anna Rachini; Govindsamy Vediyappan; Donatella Pietrella; Roberta Spaccapelo; Anna Vecchiarelli; Alistair J P Brown; Christophe d'Enfert
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

3.  Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.

Authors:  Chiatogu Onyewu; Jill R Blankenship; Maurizio Del Poeta; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

4.  Prevalence and associated factors of intertrigo in aged nursing home residents: a multi-center cross-sectional prevalence study.

Authors:  Sabrina Gabriel; Elisabeth Hahnel; Ulrike Blume-Peytavi; Jan Kottner
Journal:  BMC Geriatr       Date:  2019-04-15       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.